HVTN 131/HPTN 090

A phase 1, multi-site, randomized clinical trial to evaluate the safety, tolerability, antiviral activity, and pharmacokinetics of anti-HIV monoclonal antibodies VRC07-523LS and 10E8VLS administered by subcutaneous infusion with Hylenex and by intravenous infusion without Hylenex®, in healthy, HIV–uninfected adult participants